Letermovir prophylaxis through day 100 post transplant is safe and effective compared with alternative CMV prophylaxis strategies following adult cord blood and haploidentical cord blood transplantation
Prashant Sharma(University of Colorado Denver), Jonathan A. Gutman(University of Colorado Denver), Maheen Z. Abidi(University of Colorado Denver), Stephanie Chase(Eastern Oregon University), Valida Bajrovic(University of Colorado Anschutz Medical Campus), Jeff Kaiser, Matthew W. Miller(Auburn University), Esther Benamu(University of Colorado Denver), Bradley Haverkos(University of Colorado Denver), Adriana Weinberg(University of Colorado Anschutz Medical Campus), Jennifer MacDonald(University of Colorado Denver), Neel Gakhar(University of Colorado Denver), Jennifer Tobin, Enkhtsetseg Purev(University of Colorado Denver)
Cited by 39
Related Papers
Monocytic Subclones Confer Resistance to Venetoclax-Based Therapy in Patients with Acute Myeloid Leukemia
|Cancer Discovery|2020|550
Coronavirus Disease 2019 in Solid Organ Transplant: A Multicenter Cohort Study
|Clinical Infectious Diseases|2020|407
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium
|Annals of Oncology|2021|328